Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR - ICR / Cancer Research Society Partnership - Research Grants

Direct Payment

$60,000.00

The Role of Microbiota and Immune Microenvironment in Breast Cancer Metastasis

FY 2020-21

Summary
Metastasis is the major cause of death for cancer patients and treatment options for patients with aggressive, highly metastatic forms of breast cancer, such as triple negative breast cancer, remain limited. The microenvironment of metastatic breast tumours is associated with poor oxygenation (hypoxia), acidic conditions and inflammation that promote disease progression. Bacteria are also present in breast tumors, but it is currently unknown whether specific types of bacteria are present in the hypoxic, acidic conditions common to aggressive breast cancer and how such bacteria may contribute to metastasis. Drs Dedhar and Finlay, together with their research teams, are studying the role that host bacteria, or microbiome, play in driving the process of metastasis in breast cancer. A major objective this research proposal is to identify and characterize the microbiome specifically associated with aggressive, metastatic disease, and to understand how these bacteria regulate the function of immune cells and inflammatory cells such as neutrophils to drive metastatic cancer. These studies aim to identify the micobiome specific to metastatic cancer and determine the functional consequences of the microbiome in regulating metastasis, with the long term goal ofestablishing the microbiome as a predictor of development of metastatic disease that could be targeted therapeutically to effectively treat patients with aggressive breast cancer.
Program
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Location
British Columbia, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
453393
Name
Dedhar Shoukat R
Region
British Columbia
Country
Canada
Orgtype
Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
The Role of Microbiota and Immune Microenvironment in Breast Cancer Metastasis
Programtype2
Operating Grants
Orgnameinp2
Direct Payment
Cihramount2
$60,000
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Keyworddelim
Immunotherapy; Targets And Biomarkers; Tumour Progression And Metastasis
Abstract
Metastasis is the major cause of death for cancer patients and treatment options for patients with aggressive, highly metastatic forms of breast cancer, such as triple negative breast cancer, remain limited. The microenvironment of metastatic breast tumours is associated with poor oxygenation (hypoxia), acidic conditions and inflammation that promote disease progression. Bacteria are also present in breast tumors, but it is currently unknown whether specific types of bacteria are present in the hypoxic, acidic conditions common to aggressive breast cancer and how such bacteria may contribute to metastasis. Drs Dedhar and Finlay, together with their research teams, are studying the role that host bacteria, or microbiome, play in driving the process of metastasis in breast cancer. A major objective this research proposal is to identify and characterize the microbiome specifically associated with aggressive, metastatic disease, and to understand how these bacteria regulate the function of immune cells and inflammatory cells such as neutrophils to drive metastatic cancer. These studies aim to identify the micobiome specific to metastatic cancer and determine the functional consequences of the microbiome in regulating metastasis, with the long term goal ofestablishing the microbiome as a predictor of development of metastatic disease that could be targeted therapeutically to effectively treat patients with aggressive breast cancer.
Competitiondate
202103
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Dedhar, Shoukat R
Approvedterm
2 ans 0 mois
Cihrcontribution2
Breast Cancer Initiative~ $60,000~ $0~
Direct Payment - $60,000 Grant (2020-21) | Canada Spends